Skip to the content
June 28, 2026
The India Wire : Top Newsportal in IndiaThe India Wire : Top Newsportal in IndiaThe India Wire : Top Newsportal in India
The India Wire: 39K+ Authentic Stories in 5 Years | India's Trusted News Portal
  • CONTACT US
  • ABOUT US
  • Founding Editors’s Note
  • TERMS & CONDITIONS
1

Vadodara Journalist Helpless in Gujarat — Scribe Fights Illegal VIO Hospital Construction Alone Since 2024, Faces Harassment as CMO Stays Silent

June 12, 2026June 12, 2026
2

How to Protect Your Savings from Inflation: The Power of Compounding Explained

June 12, 2026
3

What the Latest IRDAI Guidelines Mean for Health Insurance Policyholders in India

June 12, 2026
4

US-Based PlatinaData.AI Launches India Centre of Excellence with ZettaMine

June 12, 2026
5

15 Questions to Ask Before Adding a Critical Illness Benefit to Your Existing Health Plan

June 12, 2026
6

Best Crypto Presale: AlphaPepe Hits USD 1.5M Raised as Friday’s AlphaSwap Early Access Fuels 500x Potential

June 12, 2026
7

Sonam Wangchuk Joins the ‘Cockroaches’: Anna Hazare 2.0 or AAP’s Stealth Revival Play? NEET Fury, Youth Discontent, and the Protest Policing Puzzle

June 6, 2026June 6, 2026

Bhagiradha Chemicals & Industries Limited

June 3, 2026

HFCL Limited

June 3, 2026
The India Wire : Top Newsportal in India
Category:
Category: Pharma
  • Home
  • Pharma

Category: Pharma

Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate Injection USP.
Pharma USFDA approval

Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate Injection USP.

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...

THE INDIA WIRE NETWORK
November 1, 2022November 1, 2022
Read More
Alembic reports 11% growth in revenue for Q4 FY22 from INR 1280 Cr. in FY21 to INR 1416 Cr.
Pharma

Alembic reports 11% growth in revenue for Q4 FY22 from INR 1280 Cr. in FY21 to INR 1416 Cr.

Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 31st March 2022. Financial HighlightsIndia Branded Business up by 25% in Q4 from...

THE INDIA WIRE NETWORK
May 2, 2022May 2, 2022
Read More
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam.
Pharma USFDA approval

Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam.

Alembic Pharmaceuticals Limited (Alembic) today announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration...

THE INDIA WIRE NETWORK
April 25, 2022April 25, 2022
Read More
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets
Pharma USFDA approval

Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets

Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval...

THE INDIA WIRE NETWORK
April 20, 2022April 20, 2022
Read More
Black Fungus: 11 Pharma Companies To Produce Amphotericin-B Dru
Covid19 Pharma

Black Fungus: 11 Pharma Companies To Produce Amphotericin-B Dru

India's drug regulator has authorized five new companies to manufacture the life-saving injection used to treat Mucormycosis in an attempt to accelerate the production of...

THE INDIA WIRE NETWORK
May 25, 2021
Read More
Alembic Pharmaceuticals recieves USFDA approval for bipolar depression.
Business Economy Pharma

Alembic Pharmaceuticals recieves USFDA approval for bipolar depression.

Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product...

THE INDIA WIRE NETWORK
May 23, 2021
Read More
Alembic announces upto 50 lakhs of financial aide for deceased Employees due to Covid 19
COVID 19 News Gujarat Pharma

Alembic announces upto 50 lakhs of financial aide for deceased Employees due to Covid 19

Alembic Pharmaceuticals Ltd has announced Financial Aid of  between  15 lakhs to 50 lakhs to their deceased employees, which is over and above all other benefits...

THE INDIA WIRE NETWORK
May 15, 2021May 15, 2021
Read More
Jubilant Pharma wins over Bracco’s Legal appeals in the United States Court of Appeals
Business India Pharma

Jubilant Pharma wins over Bracco’s Legal appeals in the United States Court of Appeals

Jubilant Pharma Limited ("Jubilant"), a subsidiary of Jubilant Pharmova Limited, announced that it has received a favorable and unanimous judgment from the United States Court...

The India Wire Team
May 8, 2021
Read More
Alembic Pharmaceuticals recieves USFDA approval for Opthalmic Solution.
Business Pharma

Alembic Pharmaceuticals recieves USFDA approval for Opthalmic Solution.

Drug firm Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, used...

The India Wire Team
May 5, 2021
Read More
Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores
Business Pharma

Alembic Pharmaceuticals Net Revenue increases 17% to Rs 5393 crores

Net Profit up 42% to Rs 1178 crores for the yearAlembic Pharmaceuticals Limited reported its consolidated financial results for the period ending 31st March 2021....

The India Wire Team
May 4, 2021
Read More

Posts pagination

1 2 Next

Corporate Announcements

  • Vadodara Journalist Helpless in Gujarat — Scribe Fights Illegal VIO Hospital Construction Alone Since 2024, Faces Harassment as CMO Stays Silent
  • How to Protect Your Savings from Inflation: The Power of Compounding Explained
  • What the Latest IRDAI Guidelines Mean for Health Insurance Policyholders in India
  • US-Based PlatinaData.AI Launches India Centre of Excellence with ZettaMine
  • 15 Questions to Ask Before Adding a Critical Illness Benefit to Your Existing Health Plan

Archives

Categories

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Recent Post

Vadodara Journalist Helpless in Gujarat — Scribe Fights Illegal VIO Hospital Construction Alone Since 2024, Faces Harassment as CMO Stays Silent

How to Protect Your Savings from Inflation: The Power of Compounding Explained

What the Latest IRDAI Guidelines Mean for Health Insurance Policyholders in India

US-Based PlatinaData.AI Launches India Centre of Excellence with ZettaMine

15 Questions to Ask Before Adding a Critical Illness Benefit to Your Existing Health Plan

Top Category

Corporate

Brand News

India

Trending

  • CONTACT US
  • ABOUT US
  • Founding Editors’s Note
  • TERMS & CONDITIONS
To the Top ↑ Up ↑
Copyright © 2026 The India Wire : Top Newsportal in India. REOFACTS MEDIA All rights reserved.
Theme: BoundlessNews By Themeinwp. Powered by WordPress.
Go to mobile version